Grand Pharmaceutical Group Limited

DB:MX6A Stock Report

Market Cap: €1.9b

Grand Pharmaceutical Group Future Growth

Future criteria checks 2/6

Grand Pharmaceutical Group is forecast to grow earnings and revenue by 2.3% and 6.2% per annum respectively. EPS is expected to grow by 1.5% per annum. Return on equity is forecast to be 13% in 3 years.

Key information

2.3%

Earnings growth rate

1.5%

EPS growth rate

Pharmaceuticals earnings growth21.6%
Revenue growth rate6.2%
Future return on equity13.0%
Analyst coverage

Low

Last updated22 Oct 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:MX6A - Analysts future estimates and past financials data (HKD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202614,0342,5262,1352,5613
12/31/202512,8982,2121,7242,0903
12/31/202411,6452,0391,6352,1783
6/30/202410,5872,4091,4511,903N/A
3/31/202410,5582,1441,6942,164N/A
12/31/202310,5301,8801,9372,425N/A
9/30/202310,4342,1391,3492,114N/A
6/30/202310,3392,3987611,804N/A
3/31/20239,9512,2397731,823N/A
12/31/20229,5622,0797851,843N/A
9/30/20229,4031,9951,0681,829N/A
6/30/20229,2441,9101,3501,815N/A
3/31/20228,9212,1561,4101,911N/A
12/31/20218,5982,4031,4692,006N/A
9/30/20218,1312,3401,4872,001N/A
6/30/20217,6642,2771,5041,995N/A
3/31/20217,0082,0351,3511,726N/A
12/31/20206,3531,7931,1971,456N/A
9/30/20206,3061,5581,0201,400N/A
6/30/20206,2591,3238431,345N/A
3/31/20206,4251,2377901,324N/A
12/31/20196,5911,1517371,304N/A
9/30/20196,4501,0481,1771,661N/A
6/30/20196,3099441,6182,017N/A
3/31/20196,1348281,3261,713N/A
12/31/20185,9587131,0341,408N/A
9/30/20185,845642535898N/A
6/30/20185,73257036387N/A
3/31/20185,251516N/A553N/A
12/31/20174,771461N/A720N/A
9/30/20174,480413N/A708N/A
6/30/20174,190364N/A696N/A
3/31/20173,943317N/A736N/A
12/31/20163,696269N/A775N/A
9/30/20163,573241N/A807N/A
6/30/20163,450213N/A839N/A
3/31/20163,348197N/A668N/A
12/31/20153,246181N/A496N/A
9/30/20153,158187N/A439N/A
6/30/20153,071194N/A382N/A
3/31/20153,097185N/A430N/A
12/31/20143,122175N/A477N/A
9/30/20143,040150N/A602N/A
6/30/20142,958126N/A728N/A
3/31/20142,808113N/A760N/A
12/31/20132,658100N/A792N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: MX6A's forecast earnings growth (2.3% per year) is above the savings rate (1%).

Earnings vs Market: MX6A's earnings (2.3% per year) are forecast to grow slower than the German market (21.1% per year).

High Growth Earnings: MX6A's earnings are forecast to grow, but not significantly.

Revenue vs Market: MX6A's revenue (6.2% per year) is forecast to grow faster than the German market (5.6% per year).

High Growth Revenue: MX6A's revenue (6.2% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: MX6A's Return on Equity is forecast to be low in 3 years time (13%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y